awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36394925-28618263-0DBD-44A5-8E33-943168D2E6D5
Q36394925-28618263-0DBD-44A5-8E33-943168D2E6D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36394925-28618263-0DBD-44A5-8E33-943168D2E6D5
Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.
P2860
Q36394925-28618263-0DBD-44A5-8E33-943168D2E6D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36394925-28618263-0DBD-44A5-8E33-943168D2E6D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd7eaf51fb7746dfe31023a4ae5cfaa32b8a7c02
P2860
Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.